There has been significant trading in the shares of Trellus (LON: TRLS), which has developed a digital platform to manage complex chronic conditions. This is already the most shares traded in a single day since February. The share price jumped 130.8% to 1.5p.
Shares in Fiinu (LON: BANK) have returned from suspension after the publication of the document for the reverse takeover of Poland-based foreign exchange brokerage Everfex. The initial payment of £8m will be satisfied by the issue of 80 million shares at 10p each and the rest will depend on performance and be payable via up to 20 million shares at 20p each. Everfex made a pre-tax profit of more than £600,000 for the four months to April 2025. The acquisition will broaden the range of activities of the company and provide opportunities for the Plugin Overdraft product. A subscription has generated £801,000 at 10p/share. The share price increased 14.3% to 11p.
Blue Star Capital (LON: BLU) investee company SatoshiPay, where it holds a 50% shareholding, has fully invested the £1m loan it provided. It paid for 72.03338 Ether and 9.26732 Coinbase Wrapped BTC digital assets. The later is backed 1:1 by native Bitcoin held by Coinbase. They are redeemable for the underlying asset. The share price is 8.06% higher at 16.75p.
Keras Resources (LON: KRS) says Utah-based Falcon Isle is planning a mining campaign for an additional 5,000 tons of rock phosphate to bolster inventories and satisfy forward orders. The Nayega manganese mine in northern Togo is starting to ramp up to full capacity. First shipments are anticipated in September. The share price rose 3.85% to 1.35p.
FALLERS
Premier African Minerals (LON: PREM) is implementing the changes identified for the plant test at the Zulu lithium and tantalum project. In the next week a decision will be made on whether to purchase the secondary spodumene float section. The original sorters still have to be replaced and the tantalum recovery circuit needs to be completed. The share price dipped 17.2% to 0.024p.
Software supplier Pennant International (LON: PEN) says that first half revenues are broadly in line from expectations, but revenues from the GenFly contract with the MoD have been delayed until next year because of new approval processes. Zeus has cut its 2025 forecast revenues by 14% to £10.7m and expects a loss of £1.7m. The 2026 pre-tax profit is maintained at £1.27m. The share price declined 10.7% to 25p.
Alex Duggan has been appointed interim chief executive of erectile dysfunction treatments developer Futura Medical (LON: FUM). Angela Hildreth is stepping down as finance director and has a six-month notice period. Eroxon sales remain unpredictable. Sales and marketing strategies are being assessed and there will be news when the interims are published in late September. The share price slipped 12.1% to 10.135p.
Metals explorer Rockfire Resources (LON: ROCK) says drilling will commence at the Molaoi zinc deposit in Greece will commence before the 15 September. There will be a 30-hole programme, and it should result in a maiden inferred germanium resource. A feasibility study will be started. The share price fell 4% to 0.12p.